Author Question: The Myers Briggs Type Indicator is an outgrowth of ___________________ psychology. a. Freudian ... (Read 97 times)

formula1

  • Hero Member
  • *****
  • Posts: 666
The Myers Briggs Type Indicator is an outgrowth of ___________________ psychology.
 
  a. Freudian
  b. Eriksonian
  c. Ego
  d. Object Relations
  e. Jungian

Question 2

Which of the following would NOT be identified by an analytical therapist as a valid statement about dream analysis?
 
  a. Dreams conceal the hidden experiences of clients and the meanings that clients attach to those experiences.
  b. Dreams might actually suggest solutions to a clients current dilemma.
  c. The clients psychological state might be presented in a dream through stories or archetypal characters.
  d. Dreams can reflect both client fears and wishes.
  e. Following a series of dreams and watching the changes in them can serve as a measure of a clients progress in therapy.



shewald78

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

Answer: e

Answer to Question 2

Answer: a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

For a complete list of videos, visit our video library